Yrjö Kerttula

733 total citations
19 papers, 638 citations indexed

About

Yrjö Kerttula is a scholar working on Epidemiology, Microbiology and Molecular Biology. According to data from OpenAlex, Yrjö Kerttula has authored 19 papers receiving a total of 638 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Epidemiology, 5 papers in Microbiology and 4 papers in Molecular Biology. Recurrent topics in Yrjö Kerttula's work include Pneumonia and Respiratory Infections (5 papers), Adipokines, Inflammation, and Metabolic Diseases (5 papers) and Bacterial Infections and Vaccines (5 papers). Yrjö Kerttula is often cited by papers focused on Pneumonia and Respiratory Infections (5 papers), Adipokines, Inflammation, and Metabolic Diseases (5 papers) and Bacterial Infections and Vaccines (5 papers). Yrjö Kerttula collaborates with scholars based in Finland and Australia. Yrjö Kerttula's co-authors include Marja‐Riitta Taskinen, Ville Valtonen, Esko A. Nikkilä, Kari Sammalkorpi, Theodor Weber, Maija Leinonen, Markku Koskela, P. Helena Mäkelä, Erja Jalonen and James C. Paton and has published in prestigious journals such as Journal of Clinical Pathology, Atherosclerosis and Metabolism.

In The Last Decade

Yrjö Kerttula

19 papers receiving 607 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yrjö Kerttula Finland 12 305 124 103 92 78 19 638
Ronald W. Quenzer United States 11 216 0.7× 98 0.8× 60 0.6× 110 1.2× 66 0.8× 14 502
Phil Barton United States 5 289 0.9× 80 0.6× 91 0.9× 214 2.3× 37 0.5× 5 605
Alan S. Coulson United States 13 262 0.9× 154 1.2× 106 1.0× 190 2.1× 13 0.2× 35 834
Christopher Louden United States 12 371 1.2× 94 0.8× 109 1.1× 45 0.5× 123 1.6× 21 674
Ulla Hohenthal Finland 18 362 1.2× 124 1.0× 102 1.0× 128 1.4× 33 0.4× 43 917
H. Kothe Germany 8 310 1.0× 95 0.8× 88 0.9× 207 2.3× 13 0.2× 18 630
M. Michele Mariscalco United States 13 195 0.6× 53 0.4× 103 1.0× 143 1.6× 23 0.3× 20 623
Anton Leighton United States 9 292 1.0× 78 0.6× 147 1.4× 152 1.7× 40 0.5× 10 758
J. Walton Tomford United States 18 411 1.3× 214 1.7× 63 0.6× 84 0.9× 21 0.3× 40 864
S Bilgrami United States 17 232 0.8× 89 0.7× 93 0.9× 65 0.7× 17 0.2× 40 707

Countries citing papers authored by Yrjö Kerttula

Since Specialization
Citations

This map shows the geographic impact of Yrjö Kerttula's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yrjö Kerttula with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yrjö Kerttula more than expected).

Fields of papers citing papers by Yrjö Kerttula

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yrjö Kerttula. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yrjö Kerttula. The network helps show where Yrjö Kerttula may publish in the future.

Co-authorship network of co-authors of Yrjö Kerttula

This figure shows the co-authorship network connecting the top 25 collaborators of Yrjö Kerttula. A scholar is included among the top collaborators of Yrjö Kerttula based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yrjö Kerttula. Yrjö Kerttula is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Jalonen, Erja, Suvi Taira, James C. Paton, et al.. (1990). Pneumolysin, produced in Bacillus subtilis as antigen in enzyme immunoassay for etiological diagnosis of pneumococcal pneumonia. Serodiagnosis and Immunotherapy in Infectious Disease. 4(6). 459–468. 20 indexed citations
2.
Jalonen, Erja, James C. Paton, Markku Koskela, Yrjö Kerttula, & Maija Leinonen. (1989). Measurement of antibody responses to pneumolysin-A promising method for the presumptive aetiological diagnosis of pneumococcal pneumonia. Journal of Infection. 19(2). 127–134. 93 indexed citations
3.
Sammalkorpi, Kari, Ville Valtonen, Yrjö Kerttula, Esko A. Nikkilä, & Marja‐Riitta Taskinen. (1988). Changes in serum lipoprotein pattern induced by acute infections. Metabolism. 37(9). 859–865. 237 indexed citations
4.
Kerttula, Yrjö & Theodor Weber. (1988). Serum lipids in pneumonia of different aetiology.. PubMed. 20(3). 184–8. 20 indexed citations
5.
Kerttula, Yrjö, Maija Leinonen, Markku Koskela, & P. Helena Mäkelä. (1987). The aetiology of pneumonia. Application of bacterial serology and basic laboratory methods. Journal of Infection. 14(1). 21–30. 90 indexed citations
6.
Kerttula, Yrjö & Theodor Weber. (1986). Serum Lipids in Viral and Bacterial Meningitis. Scandinavian Journal of Infectious Diseases. 18(3). 211–215. 28 indexed citations
7.
Kerttula, Yrjö, Martti Vaara, L. Pyhälä, et al.. (1986). Effect of bacterial lipopolysaccharide on serum lipids and on the development of aortic atherosclerosis in rabbits. Atherosclerosis. 59(3). 307–312. 7 indexed citations
8.
Weber, Theodor & Yrjö Kerttula. (1986). Carcinoembryonic Antigen (CEA) in Blood in Cases of Pneumonia. Scandinavian Journal of Infectious Diseases. 18(6). 547–550. 12 indexed citations
9.
Kerttula, Yrjö & Theodor Weber. (1986). Serum angiotensin converting enzyme in pneumonias.. Journal of Clinical Pathology. 39(11). 1250–1253. 8 indexed citations
10.
Kerttula, Yrjö, Martti Vaara, & L. Pyhälä. (1984). Effect of bacterial lipopolysaccharide on serum high density lipoprotein cholesterol in rabbits. Atherosclerosis. 52(1). 123–126. 11 indexed citations
11.
Kerttula, Yrjö, et al.. (1983). Fever of Unknown Origin: A Follow-up Investigation of 34 Patients. Scandinavian Journal of Infectious Diseases. 15(2). 185–187. 12 indexed citations
12.
Kerttula, Yrjö, Theodor Weber, & Pirjo Tanner. (1981). Effect of immune complexes on plasma HDL-cholesterol in rabbits. Atherosclerosis. 38(3-4). 395–399. 4 indexed citations
13.
Kerttula, Yrjö, Theodor Weber, & Pirjo Tanner. (1981). High density lipoprotein cholesterol in haemorrhagic hyperlipidaemia in rabbits. Atherosclerosis. 38(3-4). 321–326. 3 indexed citations
14.
Kerttula, Yrjö, Theodor Weber, & O Wäger. (1980). Effects of immune complexes on plasma triglycerides in rabbits. Atherosclerosis. 35(4). 451–459. 3 indexed citations
15.
Kerttula, Yrjö, et al.. (1980). Immunity to Diphtheria in Helsinki in 1975. Scandinavian Journal of Infectious Diseases. 12(1). 37–39. 17 indexed citations
16.
Kerttula, Yrjö. (1979). The Removal of Exogenous Triglycerides in Haemorrhagic Hyperlipidaemia in Rabbits. Acta Medica Scandinavica. 205(1-6). 309–311. 1 indexed citations
17.
Klockars, Matti, Sakari Reitamo, Theodor Weber, & Yrjö Kerttula. (1978). Cerebro-spinal fluid lysozyme in bacterial and viral meningitis.. 203. 71–74. 21 indexed citations
18.
Klockars, Matti, et al.. (1978). Cerebrospinal Fluid Lysozyme in Bacterial and Viral Meningitis. Acta Medica Scandinavica. 203(1-6). 71–74. 45 indexed citations
19.
Kerttula, Yrjö. (1978). Fat loading tests in haemorrhagic hyperlipidaemia in rabbits. European Journal of Clinical Investigation. 8(4). 233–242. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026